Documentos relacionados

1. Therapeutic Effects of High-Intensity Interval Training Exercise Alone and Its Combination with Ecdysterone Against Amyloid Beta-Induced Rat Model of Alzheimer's Disease: A Behavioral, Biochemical, and Histological Study.
2. A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer's disease.
3. Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer's disease.
4. Rosavin thwarts amyloid-ß-induced macromolecular damages and neurotoxicity, exhibiting anti-Alzheimer's disease activity in Wister rat model.
5. Metformin mitigates amyloid ß_1-40-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation.
6. Amyloid beta (1-42) downregulates adenosine-2b receptors in addition to mitochondrial impairment and cholinergic dysfunction in memory-sensitive mouse brain regions.
7. Amyloid-beta induced paralysis is reduced by cholecalciferol through inhibition of the steroid-signaling pathway in an Alzheimer model of <i>Caenorhabditis elegans</i>.
8. Injection of amyloid-ß to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer's disease.
9. Uptake of Aß by OATPs might be a new pathophysiological mechanism of Alzheimer disease.
10. Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aß_1-42-Induced Neuroinflammation.